Re: Darolutamide plus Androgen-deprivation Therapy and Docetaxel in Metastatic Hormone-sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial
Ghamande, Salil S, Klaassen, Zachary, Wallis, Christopher J D
Published in European urology (01.09.2023)
Published in European urology (01.09.2023)
Get full text
Journal Article